Back to announcement
20240528_PRIM_Ringkasan Risalah//Risalah RUPS_31643447_lamp1.pdf
RUPS minutes Needs review PRIMSource file signed link, expires in 15 minutes
Extracted text 6
Page 1
RINGKASAN RISALAH RUPS
A. Pelaksanaan RUPST
Tanggal : 11 Juni 2024
Tempat : Prima Sky Cafe & Lounge, VIP Room, Jalan Sampul Nomor 3, UNPRI Main
Campus Lantai 22
Waktu : 10.30
Mata Acara :
1. Persetujuan Laporan Tahunan dan Laporan Keuangan Tahunan Tahun Buku 2023
2. Persetujuan Penggunaan Laba Bersih untuk tahun buku yang berakhir pada tanggal 31 Desember 2023
3. Persetujuan Penunjukkan Akuntan Publik dan/atau Kantor Akuntan Publik untuk tahun buku yang
berakhir pada tanggal 31 Desember 2024
4. Penetapan remunerasi Direksi dan/atau Dewan Komisaris Perseroan serta pendelegasian wewenang
kepada Dewan Komisaris untuk penetapan remunerasi bagi Direksi dan Dewan Komisaris Perseroan
5. Persetujuan pengangkatan kembali/perubahan susunan Direksi
B. Kehadiran Direksi dan Dewan Komisaris
Anggota Direksi yang hadir:
Direktur Utama : Dr. Tommy Leonard, SH., M.Kn
Direktur : Ir. Mok Siu Pen
Anggota Dewan Komisaris yang hadir:
Komisaris Utama : Dr. Heriyanti, SH., MKn.
C. Jumlah saham yang hadir : 2.197.172.200
Persentase saham yang hadir : 65,037%
D. Pemberian kesempatan untuk mengajukan pertanyaan dan/atau memberikan pendapat
Rapat telah memberikan kesempatan untuk mengajukan pertanyaan dan/atau memberikan pendapat pada
setiap mata acara Rapat.
E. Jumlah yang mengajukan pertanyaan dan/atau memberikan pendapat
Tidak terdapat pemegang saham yang mengajukan pertanyaan dan/atau memberikan pendapat terkait mata
acara Rapat.
Page 2
F. Mekanisme pengambilan keputusan
Mekanisme pengambilan keputusan dalam Rapat dilakukan dengan cara musyawarah untuk mufakat. Apabila
musyawarah untuk mufakat tidak tercapai, maka dilakukan pemungutan suara.
G. Hasil pengambilan keputusan
Hasil pengambilan keputusan dilakukan dengan pemungutan suara/voting, jumlah suara dan persentase
keputusan rapat dari seluruh saham dengan hak suara yang hadir dalam Rapat yaitu:
Mata Setuju Tidak Setuju Abstain Keputusan
Acara
Lembar % Lembar % Lembar %
1 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Menyetujui
2 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Menyetujui
3 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Menyetujui
4 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Menyetujui
5 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Menyetujui
H. Hasil Keputusan Rapat
Dalam Rapat telah diambil keputusan sebagai berikut :
RUPST
A. Mata Acara Rapat Pertama
Persetujuan Laporan Tahunan dan Laporan Keuangan Tahunan Tahun Buku 2023
Keputusan:
• Persetujuan Laporan Tahunan Tahun Buku 2023 termasuk di dalamnya Laporan Pengawasan Dewan
Komisaris dan Pengesahan Laporan Keuangan Perseroan yang berakhir pada tanggal 31 Desember
2023.
B. Mata Acara Rapat Kedua
Persetujuan Penggunaan Laba Bersih untuk tahun buku yang berakhir pada tanggal 31 Desember 2023
Keputusan:
• Menggunakan sepenuhnya Laba Bersih Perseroan tahun buku 2023 untuk memperkuat struktur
permodalan demi mendukung target pertumbuhan dan pengembangan bisnis yang telah direncanakan.
D. Mata Acara Rapat Ketiga
Persetujuan Penunjukan Akuntan Publik dan/atau Kantor Akuntan Publik untuk tahun buku yang berakhir pada
tanggal 31 Desember 2024.
Keputusan:
Page 3
• Menunjuk KAP Jamaludin, Ardi, Sukimto & Rekan sebagai akuntan publik independen yang akan
melakukan audit atas buku Perseroan untuk tahun buku yang berakhir pada tanggal 31 Desember 2024.
• Pemberian wewenang kepada Dewan Komisaris Perseroan untuk menetapkan honorarium beserta
persyaratan penunjukkan KAP.
E. Mata Acara Rapat Keempat
Penetapan remunerasi Direksi dan/atau Dewan Komisaris Perseroan serta pelimpahan wewenang kepada
Dewan Komisaris untuk penetapan remunerasi bagi Direksi dan Dewan Komisaris Perseroan.
Keputusan:
Penetapan remunerasi Direksi dan/atau Dewan Komisaris serta pelimpahan wewenang kepada Dewan
Komisaris untuk penetapan remunerasi bagi Direksi dan Dewan Komisaris.
F. Mata Acara Rapat Kelima
Persetujuan pengangkatan kembali/perubahan susunan Direksi
Keputusan:
Mengangkat dan menetapkan susunan Direksi Perseroan yang baru, dengan mempertimbangkan usulan dari
Komite Nominasi dan Remunerasi Perseroan dan dilaksanakan sesuai ketentuan Anggaran Dasar Perseroan dan
peraturan Otoritas Jasa Keuangan. Terhitung sejak tanggal RUPS, susunan Direksi dan Komisaris adalah sebagai
berikut:
Direksi
Direktur Utama : Dr. Tommy Leonard, SH., MKn.
Direktur : Ir. Mok Siu Pen
Direktur : dr. Wienaldi
Komisaris
Komisaris Utama : Dr. Heriyanti, SH., MKn.
Komisaris Independen : Dr. dr. Suhartina Darmadi, MKM., M. Biomed
Medan, 11 Juni 2024
Direksi Perseroan
Page 4
SUMMARY OF MINUTES OF GMS
A. AGMS Implementation
Date : June 11, 2024
Venue : Prima Sky Cafe & Lounge, VIP Room, Jalan Sampul Nomor 3, UNPRI Main
Campus Lantai 22
Time : 10.30
Agenda:
AGMS
1. Approval of the 2023 Annual Report and Financial Statements
2. Approval for the use of Net Profit for the financial year ended December 31, 2023
3. Approval of Appointment of Public Accountant and/or Public Accounting Firm for the financial year
ending on December 31, 2024
4. Determination of remuneration for the Board of Directors and/or Board of Commissioners of the
Company and delegation of authority to the Board of Commissioners for determining remuneration
for the Board of Directors and Board of Commissioners of the Company.
5. Approval of reappointment/change in the composition of the Board of Directors
B. Attendance of the Board of Directors and Board of Commissioners
Board of Directors presence
President Director : Dr. Tommy Leonard, SH., M.Kn
Director : Ir. Mok Siu Pen
Board of Commissioners presence
President Commissioner : Dr. Heriyanti, SH., MKn.
C. Number of shares present : 2.197.172.200
Percentage of shares present : 65,037%
D. Opportunities to ask questions and/or give opinions
The Meeting has given opportunity to the shareholder, to ask questions and/or provide opinions regarding
each agenda item of the Meeting.
E. Number of people asking questions and/or giving opinions
There were no shareholders who asked questions and/or gave opinions regarding the agenda of the Meeting.
Page 5
F. Decision-making mechanism
The decision-making mechanism in the Meeting is carried out by means of deliberation for consensus. If
deliberation to reach consensus is not reached, then a vote will be held.
G. Result of decision
The results of the decision making are carried out by voting, the number of votes and the percentage of
meeting decisions from all shares with voting rights present at the Meeting, which:
Agenda Approve Reject Abstain Decision
Share % Share % Share %
1 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Approved
2 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Approved
3 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Approved
4 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Approved
5 2.196.847.200 99,985% 300.000 0,014% 25.000 0,001% Approved
H. Results of Meeting Resolutions
In the Meeting the following decisions have been made:
AGMS
A. First Agenda
Approval of the 2023 Annual Report and Financial Statements
Decision:
• Approval of the Annual Report of the Financial Year 2023, including the Board of Commissioners Oversight
Report and Ratification of the Company's Financial Statements ended on December 31, 2023.
B. Second Agenda
Approval for the Use of Net Profit for the financial year ended December 31, 2023
Decision:
• Make full use of the Company's Net Profit for the financial year 2023 to strengthen the capital structure to
support the planned growth and business development targets.
C. Third Agenda
Approval of Appointment of Public Accountant and/or Public Accounting Firm for the financial year ended 31
December 2024
Page 6
Decision:
• Advised to appoint KAP Jamaludin, Ardi, Sukimto & Partners as an independent public accountant who will
conduct an audit of the Company's financial statement for the year ended December 31, 2024.
• Granting authority to the Company's Board of Commissioners to determine the KAP's honorarium as well as
the requirement.
D. Fourth Agenda
Determination of remuneration for the Board of Directors and/or Board of Commissioners of the Company and
delegation of authority to the Board of Commissioners to determine remuneration for the Board of Directors
and Board of Commissioners of the Company.
Decision:
Determination of remuneration for the Board of Directors and/or Board of Commissioners as well as delegation
of authority to the Company's Board of Commissioners to determine remuneration for the Board of Directors
and Board of Commissioners.
D. Fifth Agenda
Approval of reappointment/change in the composition of the Board of Directors
Decision:
To appoint and determine the new composition of the Company's Board of Directors, taking into account the
proposal of the Company's Nomination and Remuneration Committee and implemented in accordance with the
provisions of the Company's Articles of Association and regulations of the Financial Services Authority. As of the
date of the GMS, the composition of the Board of Directors and Commissioners is as follows:
Board of Directors
President Director : Dr. Tommy Leonard, SH., MKn.
Director : Ir. Mok Siu Pen
Director : dr. Wienaldi
Board of Commissioners
President Commissioner : Dr. Heriyanti, SH., MKn.
Independent Commissioner : Dr. dr. Suhartina Darmadi, MKM., M. Biomed
Medan, June 11, 2024
Board of Directors
RUPS extracted from this filing
| Emiten | |
| Type | RUPS Tahunan |
| Held | 11 Jun 2024 · – |
| Present | — (—) |
| Chair | — |
Agenda 1
approved
For
2,196,847,200
—
Against
300,000
99.98%
Abstain
25,000
0.00%
- Persetujuan Laporan Tahunan Tahun Buku 2023 termasuk di dalamnya Laporan Pengawasan Dewan
Agenda 2
approved
For
2,196,847,200
—
Against
300,000
99.98%
Abstain
25,000
0.00%
- Menggunakan sepenuhnya Laba Bersih Perseroan tahun buku 2023 untuk memperkuat struktur
Agenda 3
approved
For
2,196,847,200
—
Against
300,000
99.98%
Abstain
25,000
0.00%
- Menunjuk KAP Jamaludin, Ardi, Sukimto & Rekan sebagai akuntan publik independen yang akan
- Pemberian wewenang kepada Dewan Komisaris Perseroan untuk menetapkan honorarium beserta
Agenda 4
approved
For
2,196,847,200
—
Against
300,000
99.98%
Abstain
25,000
0.00%
Agenda 5
approved
For
2,196,847,200
—
Against
300,000
99.98%
Abstain
25,000
0.00%
- Approval of the Annual Report of the Financial Year 2023, including the Board of Commissioners Oversight
- Make full use of the Company's Net Profit for the financial year 2023 to strengthen the capital structure to
- Advised to appoint KAP Jamaludin, Ardi, Sukimto & Partners as an independent public accountant who will
- Granting authority to the Company's Board of Commissioners to determine the KAP's honorarium as well as
Names mentioned 10 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Dr. Tommy Leonard
p.1 ×8
unresolved
person
Dr. Heriyanti
p.1 ×8
unresolved
org
Sukimto & Rekan
p.3
unresolved
person
dr. Wienaldi
p.3 ×2
unresolved
person
Dr. dr. Suhartina Darmadi
p.3 ×2
unresolved
org
Sukimto & Partners
p.6
unresolved
org
Financial Services Authority
p.6
Extraction attempts how the parser did, and what it refused
Rule parser
Partial
confidence 0.444
889 ms
12 Sep 2026 23:02
no shares_present; no pct_present
Raw output
{'agenda': [{'approved': True,
'pct_abstain': '0.001',
'pct_against': '99.985',
'resolution_items': ['Persetujuan Laporan Tahunan Tahun Buku 2023 '
'termasuk di dalamnya Laporan Pengawasan '
'Dewan'],
'resolution_text': '• Persetujuan Laporan Tahunan Tahun Buku 2023 '
'termasuk di dalamnya Laporan Pengawasan Dewan '
'Komisaris dan Pengesahan Laporan Keuangan '
'Perseroan yang berakhir pada tanggal 31 '
'Desember 2023. B.',
'seq': 1,
'votes_abstain': '25000',
'votes_against': '300000',
'votes_for': '2196847200'},
{'approved': True,
'pct_abstain': '0.001',
'pct_against': '99.985',
'resolution_items': ['Menggunakan sepenuhnya Laba Bersih '
'Perseroan tahun buku 2023 untuk memperkuat '
'struktur'],
'resolution_text': '• Menggunakan sepenuhnya Laba Bersih '
'Perseroan tahun buku 2023 untuk memperkuat '
'struktur permodalan demi mendukung target '
'pertumbuhan dan pengembangan bisnis yang '
'telah direncanakan. D.',
'seq': 2,
'votes_abstain': '25000',
'votes_against': '300000',
'votes_for': '2196847200'},
{'approved': True,
'pct_abstain': '0.001',
'pct_against': '99.985',
'resolution_items': ['Menunjuk KAP Jamaludin, Ardi, Sukimto & '
'Rekan sebagai akuntan publik independen '
'yang akan',
'Pemberian wewenang kepada Dewan Komisaris '
'Perseroan untuk menetapkan honorarium '
'beserta'],
'resolution_text': '• Menunjuk KAP Jamaludin, Ardi, Sukimto & '
'Rekan sebagai akuntan publik independen yang '
'akan melakukan audit atas buku Perseroan '
'untuk tahun buku yang berakhir pada tanggal '
'31 Desember 2024. • Pemberian wewenang kepada '
'Dewan Komisaris Perseroan untuk menetapkan '
'honorarium beserta persyaratan penunjukkan '
'KAP. E.',
'seq': 3,
'votes_abstain': '25000',
'votes_against': '300000',
'votes_for': '2196847200'},
{'approved': True,
'pct_abstain': '0.001',
'pct_against': '99.985',
'resolution_items': [],
'resolution_text': 'Penetapan remunerasi Direksi dan/atau Dewan '
'Komisaris serta pelimpahan wewenang kepada '
'Dewan Komisaris untuk penetapan remunerasi '
'bagi Direksi dan Dewan Komisaris. F.',
'seq': 4,
'votes_abstain': '25000',
'votes_against': '300000',
'votes_for': '2196847200'},
{'approved': True,
'pct_abstain': '0.001',
'pct_against': '99.985',
'resolution_items': ['Approval of the Annual Report of the '
'Financial Year 2023, including the Board of '
'Commissioners Oversight',
"Make full use of the Company's Net Profit "
'for the financial year 2023 to strengthen '
'the capital structure to',
'Advised to appoint KAP Jamaludin, Ardi, '
'Sukimto & Partners as an independent public '
'accountant who will',
"Granting authority to the Company's Board "
"of Commissioners to determine the KAP's "
'honorarium as well as'],
'resolution_text': 'Mengangkat dan menetapkan susunan Direksi '
'Perseroan yang baru, dengan mempertimbangkan '
'usulan dari Komite Nominasi dan Remunerasi '
'Perseroan dan dilaksanakan sesuai ketentuan '
'Anggaran Dasar Perseroan dan peraturan '
'Otoritas Jasa Keuangan. Terhitung sejak '
'tanggal RUPS, susunan Direksi dan Komisaris '
'adalah sebagai berikut: Direksi Direktur '
'Utama : Dr. Tommy Leonard, SH., MKn. Direktur '
': Ir. Mok Siu Pen Direktur : dr. Wienaldi '
'Komisaris Komisaris Utama : Dr. Heriyanti, '
'SH., MKn. Komisaris Independen : Dr. dr. '
'Suhartina Darmadi, MKM., M. Biomed Medan, 11 '
'Juni 2024 Direksi Perseroan SUMMARY OF '
'MINUTES OF GMS A. AGMS Implementation Date : '
'June 11, 2024 Venue : Prima Sky Cafe & '
'Lounge, VIP Room, Jalan Sampul Nomor 3, UNPRI '
'Main Campus Lantai 22 Time : 10.30 Agenda: '
'AGMS 1. Approval of the 2023 Annual Report '
'and Financial Statements 2. Approval for the '
'use of Net Profit for the financial year '
'ended December 31, 2023 3. Approval of '
'Appointment of Public Accountant and/or '
'Public Accounting Firm for the financial year '
'ending on December 31, 2024 4. Determination '
'of remuneration for the Board of Directors '
'and/or Board of Commissioners of the Company '
'and delegation of authority to the Board of '
'Commissioners for determining remuneration '
'for the Board of Directors and Board of '
'Commissioners of the Company. 5. Approval of '
'reappointment/change in the composition of '
'the Board of Directors B. Attendance of the '
'Board of Directors and Board of Commissioners '
'Board of Directors presence President '
'Director : Dr. Tommy Leonard, SH., M.Kn '
'Director : Ir. Mok Siu Pen Board of '
'Commissioners presence President Commissioner '
': Dr. Heriyanti, SH., MKn. C. Number of '
'shares present : 2.197.172.200 Percentage of '
'shares present : 65,037% D. Opportunities to '
'ask questions and/or give opinions The '
'Meeting has given opportunity to the '
'shareholder, to ask questions and/or provide '
'opinions regarding each agenda item of the '
'Meeting. E. Number of people asking questions '
'and/or giving opinions There were no '
'shareholders who asked questions and/or gave '
'opinions regarding the agenda of the Meeting. '
'F. Decision-making mechanism The '
'decision-making mechanism in the Meeting is '
'carried out by means of deliberation for '
'consensus. If deliberation to reach consensus '
'is not reached, then a vote will be held. G. '
'Result of decision The results of the '
'decision making are carried out by voting, '
'the number of votes and the percentage of '
'meeting decisions from all shares with voting '
'rights present at the Meeting, which: Agenda '
'Approve Reject Share % Share 1 2.196.847.200 '
'99,985% 300.000 2 2.196.847.200 99,985% '
'300.000 3 2.196.847.200 99,985% 300.000 4 '
'2.196.847.200 99,985% 300.000 5 2.196.847.200 '
'99,985% 300.000 H. Results of Meeting '
'Resolutions In the Meeting the following '
'decisions have been made: AGMS A. First '
'Agenda Approval of the 2023 Annual Report and '
'Financial Statements Decision: • Approval of '
'the Annual Report of the Financial Year 2023, '
'including the Board of Commissioners '
'Oversight Report and Ratification of the '
"Company's Financial Statements ended on "
'December 31, 2023. B. Second Agenda Approval '
'for the Use of Net Profit for the financial '
'year ended December 31, 2023 Decision: • Make '
"full use of the Company's Net Profit for the "
'financial year 2023 to strengthen the capital '
'structure to support the planned growth and '
'business development targets. C. Third Agenda '
'Approval of Appointment of Public Accountant '
'and/or Public Accounting Firm for the '
'financial year ended 31 December 2024 '
'Decision: • Advised to appoint KAP Jamaludin, '
'Ardi, Sukimto & Partners as an independent '
'public accountant who will conduct an audit '
"of the Company's financial statement for the "
'year ended December 31, 2024. • Granting '
"authority to the Company's Board of "
"Commissioners to determine the KAP's "
'honorarium as well as the requirement. D. '
'Fourth Agenda Determination of remuneration '
'for the Board of Directors and/or Board of '
'Commissioners of the Company and delegation '
'of authority to the Board of Commissioners to '
'determine remuneration for the Board of '
'Directors and Board of Commissioners of the '
'Company. Decision: Determination of '
'remuneration for the Board of Directors '
'and/or Board of Commissioners as well as '
"delegation of authority to the Company's "
'Board of Commissioners to determine '
'remuneration for the Board of Directors and '
'Board of Commissioners. D. Fifth Agenda '
'Approval of reappointment/change in the '
'composition of the Board of Directors '
'Decision: To appoint and determine the new '
"composition of the Company's Board of "
'Directors, taking into account the proposal '
"of the Company's Nomination and Remuneration "
'Committee and implemented in accordance with '
"the provisions of the Company's Articles of "
'Association and regulations of the Financial '
'Services Authority. As of the date of the '
'GMS, the composition of the Board of '
'Directors and Commissioners is as follows: '
'Board of Directors President Director : Dr. '
'Tommy Leonard, SH., MKn. Director : Ir. Mok '
'Siu Pen Director : dr. Wienaldi Board of '
'Commissioners President Commissioner : Dr. '
'Heriyanti, SH., MKn. Independent Commissioner '
': Dr. dr. Suhartina Darmadi, MKM., M. Biomed '
'Medan, June 11, 2024 Board of Directors',
'seq': 5,
'title': '5 H. Hasil',
'votes_abstain': '25000',
'votes_against': '300000',
'votes_for': '2196847200'}],
'is_electronic': False,
'meeting_date': '2024-06-11',
'meeting_type': 'AGM',
'venue': 'Prima Sky Cafe & Lounge, VIP Room, Jalan Sampul Nomor 3, UNPRI Main '
'Campus Lantai 22'}